Thursday, May 5, 2016

Teva Pharm finalizing asset sales to clear Allergan deal -source

May 5 (Reuters) - Teva Pharmaceutical Industries Ltd

is finalizing as much as $2 billion in asset sale

agreements to win U.S. antitrust clearance for its $40.5 billion

acquisition of Allergan Plc's...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)